HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diane M Citron Selected Research

Ertapenem (Invanz)

4/2009Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
4/2009Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
2/2008In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
9/2007Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
11/2005Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.
11/2002Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
9/2002General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.
4/2002Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diane M Citron Research Topics

Disease

30Infections
11/2020 - 03/2002
9Wounds and Injuries (Trauma)
01/2018 - 08/2004
8Clostridium Infections
11/2021 - 11/2011
7Diabetic Foot
02/2017 - 11/2005
6Intraabdominal Infections
08/2018 - 01/2006
6Bites and Stings (Sting)
01/2018 - 03/2002
4Soft Tissue Infections
02/2017 - 09/2002
4Sinusitis
01/2007 - 02/2002
2Cross Infection (Nosocomial Infection)
04/2017 - 12/2009
2Diarrhea
04/2016 - 12/2009
2Reinfection
09/2012 - 08/2012
2Coinfection
07/2011 - 04/2009
2Pelvic Infection
05/2011 - 11/2002
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2007 - 04/2003
2Human Bites (Bite, Human)
09/2002 - 03/2002
1Bacteremia
02/2017
1Osteomyelitis
08/2014
1Weight Gain
09/2012
1Cystic Fibrosis (Mucoviscidosis)
02/2010
1Shock
06/2009
1Aspiration Pneumonia
01/2007
1Peritonitis
08/2006
1Cellulitis
03/2005
1Bacterial Vaginosis
08/2002

Drug/Important Bio-Agent (IBA)

10Anti-Bacterial Agents (Antibiotics)IBA
08/2018 - 03/2002
8Ertapenem (Invanz)FDA Link
04/2009 - 04/2002
6VancomycinFDA LinkGeneric
08/2018 - 04/2010
6Anti-Infective Agents (Microbicides)IBA
01/2017 - 02/2002
5Methicillin (Metin)FDA Link
04/2010 - 08/2006
4FluoroquinolonesIBA
04/2017 - 04/2003
4Moxifloxacin (Avelox)FDA Link
12/2011 - 01/2006
4AgarIBA
05/2009 - 01/2005
4Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
09/2007 - 09/2002
3Levofloxacin (Levaquin)FDA Link
08/2014 - 02/2008
3Linezolid (Zyvox)FDA Link
08/2014 - 03/2005
3AntralIBA
09/2003 - 02/2002
2bezlotoxumabIBA
11/2021 - 01/2020
2CB-183,315IBA
11/2020 - 04/2016
2pexigananIBA
12/2017 - 01/2017
2DaptomycinFDA Link
08/2014 - 04/2010
2dalbavancinIBA
08/2014 - 08/2006
2CeftarolineFDA Link
07/2013 - 12/2012
2FidaxomicinIBA
08/2012 - 11/2011
2Pharmaceutical PreparationsIBA
11/2011 - 08/2011
2Carbapenems (Carbapenem Antibiotics)IBA
08/2011 - 02/2008
2Metronidazole (Metric)FDA LinkGeneric
07/2011 - 11/2002
2garenoxacinIBA
05/2011 - 03/2002
2Meropenem (Merrem)FDA LinkGeneric
04/2009 - 09/2002
2ImipenemFDA Link
04/2009 - 02/2008
2DoripenemFDA Link
04/2009 - 02/2008
2telithromycin (Ketek)FDA Link
01/2007 - 06/2003
1Monoclonal AntibodiesIBA
11/2021
1actoxumabIBA
01/2020
1eravacyclineIBA
08/2018
1omadacyclineIBA
01/2018
1Cephalosporins (Cephalosporin Antibiotics)IBA
04/2017
1tedizolidIBA
02/2017
1ridinilazoleIBA
08/2016
1LipopeptidesIBA
04/2016
1Rifampin (Rifampicin)FDA LinkGeneric
08/2014
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
08/2014
1Doxycycline (Periostat)FDA LinkGeneric
08/2014
1avibactamIBA
07/2013
1ProdrugsIBA
12/2012
1MBX-500IBA
09/2012
1Explosive Agents (Explosives)IBA
08/2011
1Oxygen (Dioxygen)IBA
02/2010
1AerosolsIBA
02/2010
1AntigensIBA
12/2009
1VenomsIBA
06/2009
1REP 3123IBA
05/2009
1Cefotetan (Cefotan)FDA Link
04/2009
1ceftobiproleIBA
11/2006
1Tigecycline (Tygacil)FDA Link
10/2006
116S Ribosomal RNAIBA
08/2006
1oritavancinIBA
02/2005
1StreptograminsIBA
01/2005
1linopristin drug combination flopristinIBA
01/2005
1telavancinFDA Link
06/2004
1delafloxacinIBA
09/2003
1Erythromycin (Erycette)FDA LinkGeneric
06/2003
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
11/2002
1Ticarcillin (Tarcil)FDA Link
11/2002
1Clindamycin (Cleocin)FDA LinkGeneric
11/2002
1Ciprofloxacin (Cipro)FDA LinkGeneric
11/2002
1Chloramphenicol (Chloromycetin)FDA Link
11/2002
1Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
11/2002
1sultamicillin (ampicillin-sulbactam)FDA LinkGeneric
11/2002
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
11/2002
1Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link
11/2002
1fropenem (faropenem)IBA
09/2002
1beta-LactamsIBA
09/2002
1cellulose sulfateIBA
08/2002
1polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric
08/2002

Therapy/Procedure

8Therapeutics
01/2020 - 11/2005
3Punctures
09/2003 - 02/2002
2Debridement
08/2011 - 09/2007
1Aftercare (After-Treatment)
08/2012
1Length of Stay
12/2009
1Curettage
09/2007